Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediateand extended-release formulations in healthy subjects
Authors:
- Jean-Francois MarierJMJean-Francois Marier
- Murray P. DucharmeMDMurray P. Ducharme
- Marika DiMarcoMDMarika DiMarco
- Mike Di SpiritoMSMike Di Spirito
- Gaetano MorelliGMGaetano Morelli
- Sudhakar K. TippabhotlaSTSudhakar K. Tippabhotla
- N. BadriNBN. Badri
- Ashok RampalARAshok Rampal
- Tausif MonifTMTausif Monif
- 1 December 2006
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 28 (12) , 2070-2080
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Maximizing efficacy and reducing the emergence of resistanceJournal of Antimicrobial Chemotherapy, 2003
- Maintaining Fluoroquinolone Class Efficacy: Review of Influencing FactorsEmerging Infectious Diseases, 2003
- Application of fluoroquinolone pharmacodynamicsJournal of Antimicrobial Chemotherapy, 2000
- FLUOROQUINOLONESInfectious Disease Clinics of North America, 2000
- Comparison of the Fluoroquinolones Based on Pharmacokinetic and Pharmacodynamic ParametersPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- Comparison of turbulent-flow chromatography with automated solid-phase extraction in 96-well plates and liquid–liquid extraction used as plasma sample preparation techniques for liquid chromatography–tandem mass spectrometryJournal of Chromatography A, 1999
- Bacterial Topoisomerases, Anti‐Topoisomerases, and Anti‐Topoisomerase ResistanceClinical Infectious Diseases, 1998
- The Importance of Pharmacokinetic/Pharmacodynamic Surrogate Markers to OutcomeClinical Pharmacokinetics, 1995
- Ofloxacin Clinical PharmacokineticsClinical Pharmacokinetics, 1992
- Pharmacokinetics of ofloxacin after parenteral and oral administrationAntimicrobial Agents and Chemotherapy, 1987